Tenenbaum Fabian 4
4 · Bellerophon Therapeutics, Inc. · Filed Jan 17, 2018
Insider Transaction Report
Form 4
Tenenbaum Fabian
Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2018-01-12+550,000→ 550,000 totalExercise: $2.03Exp: 2028-01-12→ Common Stock (550,000 underlying) - Award
Common Stock
2018-01-12+55,419→ 318,469 total
Footnotes (1)
- [F1]This option was granted on January 12, 2018. This option vests in quarterly installments over a four-year period from the date of grant.